Jennifer Cote is Chief Financial Officer of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 168,738 shares of HBIO, which is worth approximately $433,656. The most recent transaction as insider was on Mar 06, 2024, when has been sold 9,920 shares (Common Stock) at a price of $4.11 per share, resulting in proceeds of $40,771. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 169K
0% 3M change
49.37% 12M change
Total Value Held $433,656

Jennifer Cote Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2024
SELL
Payment of exercise price or tax liability
$40,771 $4.11 p/Share
9,920 Reduced 5.55%
168,738 Common Stock
Mar 05 2024
BUY
Grant, award, or other acquisition
-
71,600 Added 28.61%
178,658 Common Stock
Dec 29 2023
SELL
Payment of exercise price or tax liability
$31,618 $5.35 p/Share
5,910 Reduced 5.23%
107,058 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
82,634 Added 42.25%
112,968 Common Stock
JC

Jennifer Cote

Chief Financial Officer
Holliston, MA

Track Institutional and Insider Activities on HBIO

Follow HARVARD BIOSCIENCE INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

News

Receive news related to HARVARD BIOSCIENCE INC

Track Activities on HBIO